CarMeN Laboratory, INRAE U1397, INSERM U1060, Groupement Hospitalier Est, University Claude Bernard Lyon 1, 59 Boulevard Pinel, 69500, Lyon, Bron, France.
Lyon Neuroscience Research Center, UMR5295, INSERM U1028, CNRS, Université Claude Bernard Lyon 1, Lyon, France.
Neurotherapeutics. 2023 Apr;20(3):789-802. doi: 10.1007/s13311-023-01368-2. Epub 2023 Mar 28.
Reperfusion therapies in acute ischemic stroke have demonstrated their efficacy in promoting clinical recovery. However, ischemia/reperfusion injury and related inflammation remain a major challenge in patient clinical management. We evaluated the spatio-temporal evolution of inflammation using sequential clinical [C]PK11195 PET-MRI in a non-human primate (NHP) stroke model mimicking endovascular thrombectomy (EVT) with a neuroprotective cyclosporine A (CsA) treatment. The NHP underwent a 110-min transient endovascular middle cerebral artery occlusion. We acquired [C]PK11195 dynamic PET-MR imaging at baseline, 7 and 30 days after intervention. Individual voxel-wise analysis was performed thanks to a baseline scan database. We quantified [C]PK11195 in anatomical regions and in lesioned areas defined on per-occlusion MR diffusion-weighted imaging and perfusion [O]HOPET imaging. [C]PK11195 parametric maps showed a clear uptake overlapping the lesion core at D7, which further increased at D30. Voxel-wise analysis identified individuals with significant inflammation at D30, with voxels located within the most severe diffusion reduction area during occlusion, mainly in the putamen. The quantitative analysis revealed that thalamic inflammation lasted until D30 and was significantly reduced in the CsA-treated group compared to the placebo. In conclusion, we showed that chronic inflammation matched ADC decrease at occlusion time, a region exposed to an initial burst of damage-associated molecular patterns, in an NHP stroke model mimicking EVT. We described secondary thalamic inflammation and the protective effect of CsA in this region. We propose that major ADC drop in the putamen during occlusion may identify individuals who could benefit from early personalized treatment targeting inflammation.
急性缺血性脑卒中的再灌注治疗已证明其在促进临床恢复方面的疗效。然而,缺血/再灌注损伤及相关炎症仍然是患者临床管理的主要挑战。我们通过模拟血管内取栓术(EVT)的非人类灵长类动物(NHP)卒中模型,使用连续的临床 [C]PK11195 PET-MRI 评估炎症的时空演变,并进行神经保护环孢素 A(CsA)治疗。NHP 经历了 110 分钟短暂的血管内大脑中动脉闭塞。我们在干预前、7 天和 30 天后采集 [C]PK11195 动态 PET-MRI 成像。通过基线扫描数据库进行了个体体素分析。我们在解剖区域和闭塞期间的磁共振弥散加权成像和灌注 [O]HOPET 成像定义的病变区域定量了 [C]PK11195。[C]PK11195 参数图显示在 D7 时明显摄取与病变核心重叠,在 D30 时进一步增加。体素分析确定了 D30 时有明显炎症的个体,这些体素位于闭塞期间弥散减少最严重的区域内,主要位于壳核。定量分析表明,丘脑炎症持续到 D30,并且在 CsA 治疗组中与安慰剂相比显著减少。总之,我们在模拟 EVT 的 NHP 卒中模型中显示,慢性炎症与闭塞时的 ADC 减少相匹配,即与损伤相关分子模式的初始爆发相关的区域。我们描述了该区域继发性丘脑炎症和 CsA 的保护作用。我们提出,在闭塞期间壳核中主要的 ADC 下降可能会识别出那些可能受益于早期针对炎症的个体化治疗的个体。